Arix Bioscience

Arix Bioscience

Arix Bioscience

Suggest edits
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 11

Portfolio

Portfolio Tracker

Add info
Add round
02 Sep 2021
Disc Medicine
Disc Medicine
$90,000,000
Venture capital (Series B)
Atlas Venture, Rock Springs Capital, OrbiMed, +7

Blood disorder biotech Disc Medicine gets $90M to bring two drugs into Phase 2

MedCity News
19 May 2020
Amplyx Pharmaceuticals, Inc
Amplyx Pharmaceuticals, Inc
$53,000,000
Venture capital (Series C)
Adage Capital Management, BioMed Ventures, RiverVest, +7

Amplyx Pharmaceuticals Closes $53M Series C Extension

FinSMEs
+1
10 Aug 2018
Artios Pharma
Artios Pharma
£65,000,000
Venture capital (Series B)
Novartis Venture Fund, IP Group Plc, Arix Bioscience, +6

DNA Damage Response Company Artios Pharma Raises £65M in Series B

FinSMEs
10 Aug 2018
Artios Pharma
Artios Pharma
£65,000,000
Venture capital (Series B)
Novartis Venture Fund, Life Sciences Partners, IP Group Plc, +7
26 Sep 2017
Autolus Ltd.
Autolus Ltd.
$80,000,000
Venture capital (Series C)
Cormorant Asset Management, Nextech Invest, Arix Bioscience, +2
01 Aug 2017
Amplyx Pharmaceuticals, Inc
Amplyx Pharmaceuticals, Inc
$67,000,000
Venture capital (Series C)
3x5 Special Opportunity Fund, NEA, BioMed Ventures, +5

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

The San Diego Union-Tribune
+1
27 Jul 2017
PreciThera, Inc.
PreciThera, Inc.
$36,000,000
Venture capital (Series A)
Fonds de solidarité FTQ, Sanderling Ventures, Emerillon Capital, +2

Precision med startup PreciThera nets $36 mln in Series A round

PE HUB
+1
27 Jul 2017
PreciThera, Inc.
PreciThera, Inc.
$36,000,000
Venture capital (Series A)
Fonds de solidarité FTQ, Sanderling Ventures, CTI Life Sciences Fund, +2

PreciThera, Inc. Completes $36 Million Series A Financing

prnewswire
+1
29 Jun 2017
LogicBio Tx
LogicBio Tx
$45,000,000
Venture capital (Series B)
OrbiMed, Edmond de Rothschild Investment Partners, OrbiMed Israel Partners, +3

Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics

GlobeNewswire News Room
+1
21 Sep 2016
Artios Pharma
Artios Pharma
$33,200,000
Venture capital (Series A)
Imperial Innovations, SV Life Sciences, Arix Bioscience, +3

Artios Pharma Raises $33.2M in Series A Funding

FinSMEs